Impact of Regulatory Action on Dose Maximalization for Vitamin <scp>B6</scp> Dietary Supplements on the Reporting Pattern for Neuropathy
Although our study has limitations, we clearly see an effect of regulatory action on the doses of vitamin B6 used in neuropathy reports. However, some cases describing neuropathy related to vitamin B6 supplementation with lower doses are still reported after the regulatory action in 2018. Therefore, the association between low-dose vitamin B6 products and neuropathy should be studied further.
Authors
- Joep Scholl (ORCID: https://orcid.org/0000-0002-9222-5965)
- Misha F. Vrolijk (ORCID: https://orcid.org/0000-0002-2751-8972)
- Corine Ekhart (ORCID: https://orcid.org/0000-0002-2252-0467)
- Florence van Hunsel (ORCID: https://orcid.org/0000-0001-8965-3224)
Institutions
- University of Groningen (NL)
- Maastricht University (NL)
- Netherlands Pharmacovigilance Centre Lareb (NL)
Publication Details
- Journal
- Pharmacoepidemiology and Drug Safety
- Published
- 2025-01-29
- DOI
- https://doi.org/10.1002/pds.70108
- Citations
- 1
- Primary Topic
- Pharmacological Effects and Toxicity Studies
- Type
- article
- Field-Weighted Citation Impact
- 3.49